Overlap between ER+ BRCA/AR+ TNBC tumor and normal samples is absent in PC2, as opposed to that observed for PRAD tumor and normal samples, showing overlap in both PCs. The gene discussed is ESR1; the disease is prostate adenocarcinoma.